You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Correction: Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study

Article Text

Article menu

See original article:

Download PDFPDF

XML
Correction
Correction: Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study

https://doi.org/10.1136/jitc-2019-000381corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Bai X, Wu D, Ma S, et al. Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study. J Immunothera Cancer 2020;8:e000381. doi: 10.1136/jitc-2019-000381

    Since the online publication of this article, the authors have noticed that the word ‘study’ in the title was missing the last letter 'y'. The correct title is ‘Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study’ and has been updated in the article. Additionally, the tables were in the incorrect order in the article.